Advancing Nuclear Medicine for Better Patient Outcomes
Pioneering innovative radiopharmaceutical solutions that transform diagnostic imaging and targeted therapy for improved healthcare worldwide.
Learn MoreThree pillars that drive our mission to transform nuclear medicine
Advancing the deployment to medicine so medicine can advance so much more. Creating solutions that directly improve patient outcomes and transform healthcare delivery.
Products exist given living, lucario is planitas loadings. Pioneering breakthrough technologies that push the boundaries of nuclear medicine and radiopharmaceutical development.
Resparcemor cor genanding amiur bragging sustanase marntactionring conditions. Deep scientific knowledge and regulatory excellence driving every aspect of our work.
Leading the future of nuclear medicine through scientific innovation and regulatory excellence
Theranuclea is dedicated to developing next-generation radiopharmaceutical solutions that enhance diagnostic accuracy and therapeutic efficacy. We combine cutting-edge nuclear science with rigorous regulatory compliance to deliver safe, effective treatments that improve patient outcomes.
Our team of world-class scientists and regulatory experts work tirelessly to advance the field of nuclear medicine, bringing innovative solutions from laboratory to clinic with unprecedented speed and precision.
To become the global leader in radiopharmaceutical innovation, transforming how diseases are diagnosed and treated through the power of nuclear medicine.
Breakthrough innovations in radiopharmaceutical development and nuclear medicine applications
Explore the fascinating world of nuclear decay with our interactive 3D visualization
Developing novel radioactive compounds for precise diagnostic imaging and targeted therapeutic applications with enhanced safety profiles.
Leveraging molecular targeting and personalized medicine approaches to optimize treatment outcomes for individual patients.
Maintaining the highest standards of quality, safety, and regulatory compliance throughout our development pipeline.
World-class experts in nuclear medicine, radiochemistry, and pharmaceutical development
Chief Executive Officer
Former VP of Nuclear Medicine at leading pharmaceutical company with 15+ years of experience in radiopharmaceutical development.
Chief Scientific Officer
Renowned radiochemist with 20+ publications in nuclear medicine and expertise in novel isotope production methods.
VP of Regulatory Affairs
Former FDA reviewer with deep expertise in radiopharmaceutical regulations and clinical trial design.
Head of Clinical Development
Clinical nuclear medicine physician with extensive experience in oncology and neurology applications.
Stay updated with our latest developments and industry insights
December 2024
We are excited to announce the successful completion of our Series A funding round, enabling acceleration of our lead radiopharmaceutical programs.
November 2024
Our innovative diagnostic radiopharmaceutical receives FDA Fast Track designation for neurological applications, expediting development timeline.
October 2024
Strategic collaboration established to advance clinical research and accelerate translation of our technologies to patient care.
Get in touch for partnerships, investment opportunities, or career inquiries
Address:
Theranuclea Inc.
123 Innovation Drive
Biotech Park, CA 94301
Email:
[email protected]
[email protected]
Phone:
+1 (555) 123-4567
For partnership and investment inquiries, please contact our business development team directly or use the form to schedule a meeting.
Join our team of innovative scientists and professionals. Send your resume and cover letter to [email protected]